@article{ba42b9bbb871442a9973e84e2498a79b,
title = "Society of Interventional Radiology Position Statement on the Endovascular Management of Acute Iliofemoral Deep Vein Thrombosis",
abstract = "Purpose: To establish the updated position of the Society of Interventional Radiology (SIR) on the endovascular management of acute iliofemoral deep vein thrombosis (DVT). Materials and Methods: A multidisciplinary writing group with expertise in treating venous diseases was convened by SIR. A comprehensive literature search was conducted to identify studies on the topic of interest. Recommendations were drafted and graded according to the updated SIR evidence grading system. A modified Delphi technique was used to achieve consensus agreement on the recommendation statements. Results: A total of 84 studies, including randomized trials, systematic reviews and meta-analyses, prospective single-arm studies, and retrospective studies were identified and included in the review. The expert writing group developed 17 recommendations that pertain to the care of patients with acute iliofemoral DVT with the use of endovascular venous interventions. Conclusions: SIR considers endovascular thrombus removal to be an acceptable treatment option in selected patients with acute iliofemoral DVT. Careful individualized risk assessment, high-quality general DVT care, and close monitoring during and after procedures should be provided.",
author = "Suresh Vedantham and Desai, {Kush R.} and Ido Weinberg and William Marston and Ronald Winokur and Sheena Patel and Kolli, {Kanti Pallav} and Ezana Azene and Kari Nelson",
note = "Funding Information: S.V. reports participation on a Data Safety Monitoring Board or Advisory Board for NERI (for NIH-sponsored BEST-CLI trial) and donation of stockings by Medi USA to patients in a study led by him. K.R.D. reports consulting fees from W.L. Gore, Philips, Cordis, Asahi Intecc, and Shockwave Medical and payment or honoraria from Cook Medical, Penumbra, Medtronic, Boston Scientific, Becton Dickinson, and Tactile Medical. I.W. reports consulting fees from Penumbra Inc. and Magneto Thrombectomy Solutions and holds leadership or fiduciary roles in the Society for Vascular Medicine. W.M. receives consulting fees from Boston Scientific/Veniti and Inari Medical. R.W. receives consulting fees from Medtronic and Tactile Medical; payment or honoraria from Medtronic, Penumbra, BD/Bard, Inari Medical, and Tactile Medical; and holds leadership or fiduciary roles in the American Vein and Lymphatic, Society American Board of Venous and Lymphatic Medicine, and Society of Interventional Radiology. E.A. reports institutional grants from Inari Medical, NIH, and Philips; receives consulting fees from Philips; and holds leadership or fiduciary roles in the SIR URM section. None of the other authors have identified a conflict of interest. Publisher Copyright: {\textcopyright} 2022 SIR",
year = "2023",
month = feb,
doi = "10.1016/j.jvir.2022.10.038",
language = "English (US)",
volume = "34",
pages = "284--299.e7",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "2",
}